Health care resource utilization and costs in patients initiating natalizumab therapy for multiple sclerosis in the United States
Abstract
Authors
B.H. Johnson M. Bonafede C. Watson
B.H. Johnson M. Bonafede C. Watson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now